LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 46 filers reported holding LYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,167,210 | -4.7% | 2,856,064 | +0.1% | 0.00% | 0.0% |
| Q2 2023 | $11,723,685 | +44377.0% | 2,852,478 | +22300.5% | 0.00% | – |
| Q1 2023 | $26,359 | -67.9% | 12,734 | -51.4% | 0.00% | – |
| Q4 2022 | $82,196 | -55.8% | 26,177 | -29.5% | 0.00% | – |
| Q3 2022 | $186,000 | +220.7% | 37,136 | +180.2% | 0.00% | – |
| Q4 2021 | $58,000 | -62.8% | 13,252 | -31.6% | 0.00% | – |
| Q2 2021 | $156,000 | -94.6% | 19,381 | -92.4% | 0.00% | -100.0% |
| Q2 2020 | $2,901,000 | – | 255,794 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,100,852 | $12,550,000 | 16.38% |
| Soleus Capital Management, L.P. | 456,138 | $5,199,000 | 0.69% |
| Ikarian Capital, LLC | 815,364 | $9,295,000 | 0.41% |
| Perceptive Advisors | 3,222,561 | $36,737,000 | 0.39% |
| Affinity Asset Advisors, LLC | 50,000 | $570,000 | 0.30% |
| RA Capital Management | 815,849 | $9,301,000 | 0.13% |
| ArrowMark Colorado Holdings LLC | 775,888 | $8,845,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 87,353 | $996,000 | 0.04% |
| Altium Capital Management LP | 5,218 | $59,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 49,000 | $559,000 | 0.01% |